Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hyperuricaemia with gout Age: Adult |
Dose: Oral – 100-200 mg Frequency: twice daily Duration: Initially, increase gradually over 2-3 weeks to 600 mg daily Note: Maximum: 800 mg daily |
|
Indication: Hyperuricaemia with gout Age: Adult |
Dose: Oral – 200 mg Frequency: daily in divided doses Note: Maintenance dose (after plasma-urate concentration is controlled) |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Mild to moderate renal impairment |
Dose: Reduce dose Note: Specific dosage reduction not specified |
|
Condition: Severe renal impairment |
Dose: Contraindicated Note: Do not use in patients with severe renal impairment |
Administration
- Take with food
- Take at regular intervals
Side Effect
- Nausea
- vomitting
- diarrhoea
- skin rashes
- renal impairment or failure
- salt and water retention
- blood dyscrasia
- jaundice
- hepatitis
- acute gout attacks
- uric acid renal calculi development if inadequate fluid intake
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Diuretics (Chlorothiazide, Chlorthalidone, Hydrochlorothiazide, Indapamide, Metolazone, Bumetanide, Ethacrynic acid, Furosemide, Torsemide, Amiloride, Eplerenone, Spironolactone, Triamterene), Pyrazinamide
|
Decreased therapeutic effect
|
|
Warfarin, Acenocoumarol, Hypoglycaemic agents, Sulfonamides
|
May potentiate action
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Acute Gout Attack
|
Can worsen gout symptoms
|
|
Blood Coagulation Disorders
|
Risk of bleeding complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 15-30° C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.